President and Chief Executive Officer
Paul Medeiros serves as President and Chief Executive Officer of Q-State Biosciences and is a member of the company’s board of directors. He is responsible for overseeing the company’s strategic corporate development, technology evolution, and for advancing its first therapeutic candidates into the clinic. Paul has nearly 25 years of global executive pharmaceutical experience with an extensive track record of success in biopharma strategy, corporate development, R&D portfolio management, and product commercialization. Prior to Q-State, Paul served as President and founding executive of Imbrium Therapeutics and directed the company’s business operations and R&D portfolio in the areas of CNS therapeutics and pain. He concurrently served as President of the associated investment / accelerator firm Greenfield BioVentures. In addition to these roles, Paul has held multiple corporate leadership positions within other biopharmaceutical companies including Mundipharma International in Cambridge UK, AVI BioPharma (now Sarepta Therapeutics), and Schering-Plough Pharmaceuticals. He began his pharma career as an MBA leadership trainee at Merck & Company. Paul has served on the boards of directors of Praxis Precision Medicines, Kolltan Pharmaceuticals and EDO Pharmaceuticals GMBH. He received his AB with Honors from Brown University and his MBA from Columbia Business School.